ZLZhenhua Li

Zhenhua Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhenhua Li has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adherence to the Dietary Index for Gut Microbiota and reduced risk of nephrolithiasis: a case–control study of Chinese adults

    by Xing Jin, Jia Li, Yuanqi Zhao, Kun Xu, Yuge Wang, Song Bai, Yashu Liu, Zhenhua Li

    Objective: Nephrolithiasis represents a substantial clinical burden worldwide. The Dietary Index for Gut Microbiota (DI-GM) assesses dietary impacts on gut microbiota. However, its association with the risk of nephrolithiasis remains unclear in Chinese adults. Methods: We conducted a case–control study using the Shenyang sub-cohort of the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort. Cases were 278 patients with nephrolithiasis. Controls were 556 healthy individuals, matched 1:2 by age and sex. Dietary intake was assessed using a validated food frequency questionnaire (FFQ) to calculate DI-GM scores. Multivariable conditional logistic regression evaluated the association. Restricted cubic spline (RCS) explored non-linear associations, and subgroup analyses were stratified by age and sex. Results: Higher DI-GM scores were significantly associated with lower risk of nephrolithiasis. After adjustment, the risk decreased progressively with increasing DI-GM scores (P for trend < 0.05). Individuals with DI-GM ≥ 8 had 83% lower risk than those scoring 0–5 (odds ratio [OR] = 0.17, 95% confidence interval [CI]: 0.08–0.36). The association was consistent across age and sex subgroups, with no non-linearity (P for non-linearity > 0.05). Conclusion: In Chinese adults, higher adherence to the DI-GM was associated with lower risk of nephrolithiasis. This finding suggests gut-friendly dietary patterns may be associated with a lower likelihood of nephrolithiasis. Future prospective studies are warranted to confirm this association.

  • Open Access

    EG-UC5T EUS-guided real-time electrode marking for completely endophytic renal tumors during laparoscopic partial nephrectomy: A preliminary case series

    by Shen Pan, Zhenhua Li, Bitian Liu

    Background and Objectives: Completely endophytic renal tumors, which are invisible on the renal surface, present substantial challenges during laparoscopic partial nephrectomy (LPN). These tumors frequently result in prolonged warm ischemia time, higher rates of positive surgical margins, and excessive loss of renal parenchyma. This preliminary retrospective case series evaluated the feasibility, safety, and efficacy of real-time electrode marking guided by the EG-UC5T EUS system for precise intraoperative projection of tumor contours onto the renal surface. Methods: Five patients with completely endophytic renal tumors (RENAL E score = 3 in all cases; mean RENAL score 9.4 ± 0.9; mean diameter 2.6 ± 0.7 cm) underwent retroperitoneal LPN with EG-UC5T EUS-assisted marking. The flexible echoendoscope was introduced through a laparoscopic port for systematic real-time ultrasound scanning to delineate tumor boundaries, depth, and relationships to adjacent structures. Immediate surface marking was then performed using a metal electrode loop advanced through the integrated 4.0-mm working channel under continuous EUS guidance. Perioperative outcomes, renal functional preservation, and early oncologic results were analyzed descriptively. Results: In this series of 5 patients, tumor localization and surface marking were successfully achieved in all 5 cases (100% success rate), with a mean localization time of 8.6 ± 2.1 min. Mean operative time was 141.6 ± 18.9 min, estimated blood loss 71 ± 47.8 mL, and warm ischemia time 27 ± 8.5 min. No intraoperative complications or conversions to open surgery occurred. Mean renal parenchymal preservation reached 92% ± 4%. Estimated glomerular filtration rate declined by 3.7 ± 1.8 mL/min/1.73 m 2 on postoperative day 1 and recovered to a decline of only 1.2 ± 0.8 mL/min/1.73 m 2 at 3 months. Negative surgical margins were obtained in all cases (mean margin distance 3.2 ± 1.1 mm). One Clavien–Dindo grade I perinephric hematoma occurred and resolved conservatively. At a median follow-up of 8 months (range 6–12 months), no local recurrence or distant metastasis was detected. Conclusions: EG-UC5T EUS-guided real-time electrode marking is a feasible, safe, and effective technique for localizing completely endophytic renal tumors during LPN. It enables precise surface projection, reduces blind resection, and achieves favorable perioperative and early oncologic outcomes. Larger prospective studies are warranted.

  • Association between oxidative balance score, genetic susceptibility and nephrolithiasis: a cohort study based on the UK Biobank

    by Zheming Li, Yashu Liu, Kun Xu, Yuanqi Zhao, Honghao Yang, Wenxu Wang, Chao Ji, Zhenhua Li, Song Bai

    The Oxidative Balance Score (OBS) is a tool to evaluate the balance of oxidative and antioxidative factors from diet and lifestyle. We aim to explore the association between OBS and the incidence of nephrolithiasis and investigate whether genetic predisposition exerts a modifying effect on this association. A total of 146,055 participants were derived from the UK Biobank without nephrolithiasis at baseline. OBS was calculated based on 13 dietary components and 5 lifestyle components. 20 single nucleotide polymorphisms (SNPs) were selected to generate a polygenic risk score (PRS) for genetic susceptibility. Cox proportional hazards regression models were used to assess the associations between OBS and the incidence of nephrolithiasis. The modifying effect of PRS was also investigated. During a mean follow-up period of 9.91 years, a total of 1,076 incident cases of nephrolithiasis were documented. After adjustment for multiple covariates, the risk of nephrolithiasis in the highest OBS quintile group decreased by 23% (HR = 0.77, 95% CI 0.63, 0.95). The negative association between OBS and nephrolithiasis was more pronounced among participants with lower genetic susceptibility. In this subgroup, participants in the highest OBS quintile had a 33% lower risk of incident nephrolithiasis compared with those in the lowest OBS quintile (HR = 0.67, 95% CI 0.49-0.91). Multiplicative interaction between OBS and genetic susceptibility was significant (P for interaction = 0.02). Our study demonstrated a negative association between OBS and the incidence of nephrolithiasis, and the protective effect was more pronounced among individuals with low genetic susceptibility.

  • Open Access

    Carcinogen metabolism and bladder cancer: role of gut microbiota in disease and prevention

    by Shen Pan, Hehe Zhu, Rui Yin, Jiaman Lin, Zhujun Wang, Wanlin Cui, Zhenhua Li, Bitian Liu

    Bladder cancer remains a significant global health concern, with environmental carcinogen exposure—particularly from tobacco-derived compounds such as aromatic amines, polycyclic aromatic hydrocarbons (PAHs), and nitrosamines—recognized as a primary etiological factor. These carcinogens undergo complex metabolic activation in the liver, bladder epithelium, and gut microbiota, generating reactive intermediates that initiate DNA damage, oxidative stress, and pro-tumorigenic signaling. This review synthesizes emerging evidence on how carcinogen-induced metabolic reprogramming contributes to bladder cancer initiation and progression, emphasizing the roles of key genetic pathways and metabolic enzymes involved in xenobiotic detoxification, DNA repair, and redox regulation. In parallel, we examine the influence of gut microbiota on carcinogen bioactivation and biotransformation, highlighting its dual role as both a metabolic modulator and a potential preventive target. We critically evaluate human observational data linking microbiome dysbiosis to bladder cancer risk, while addressing limitations such as small cohort sizes and confounders like diet and age. Finally, we discuss promising strategies for risk mitigation, including microbiome-directed interventions, dietary modulation, and chemopreventive agents that counteract carcinogenic effects. By integrating molecular oncology, toxicogenomics, and host-microbiome interactions, this review provides a mechanistic framework for understanding bladder cancer etiology and identifies novel opportunities for preventive and precision interventions.


  • Open Access

    The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives

    by Shen Pan, Wanlin Cui, Jiaman Lin, Zhujun Wang, Zhenhua Li, Bitian Liu

    Bladder cancer (BC) represents a paradigm of infection-associated malignancy in which microbial dysbiosis, immune aging, and tumor microenvironmental remodeling converge to shape disease progression. Increasing evidence highlights the dual role of the urinary and gut microbiota in modulating bladder carcinogenesis through infection-driven inflammation and immune dysfunction. Chronic exposure to uropathogens and microbial imbalance disrupts epithelial integrity, promotes extracellular matrix degradation, and reprograms local immune signaling, collectively fostering a tumor-permissive niche. Concurrently, immunosenescence exacerbates microbial persistence and impairs antitumor immunity, reinforcing a pathogenic feedback loop between infection and immune decline. This review integrates current insights from microbiome research, tumor immunology, and microbial pathogenesis to delineate the mechanistic continuum linking infection, dysbiosis, and immune remodeling in BC. Finally, we discuss emerging microbiome-targeted and immunomodulatory strategies aimed at restoring microbial–immune equilibrium and improving therapeutic efficacy. Together, these perspectives provide a refined conceptual framework for understanding infection-driven oncogenesis and guiding precision interventions in BC.


  • Open Access

    Therapeutic targeting SPI1 in combination with erastin promotes ferroptosis in ccRCC

    by Wei Xue, Zhengqi Wu, Jixin Li, Peng Jin, Yuze Zhu, Zhiyuan Li, Zhijiao Wang, Zhenhua Li, Xiang Fei

    Clear cell renal cell carcinoma is the most common renal cell carcinoma subtype with a poor prognosis. The SPI1/Pu.1, which encodes a member of the E26-transformation-specific family of transcription factors, is highly expressed and associated with poor prognosis in renal cell carcinoma. Ferroptosis, a form of cell death distinct from apoptosis, pyroptosis, and necrosis, is characterized by iron accumulation and lipid peroxidation. Although the role of SPI1 in renal cell carcinoma is recognized, its relationship with ferroptosis remains unclear. In this study, we demonstrate that SPI1 is differentially overexpressed in renal cell carcinoma and associated with unfavorable prognosis. We also show that knockdown of SPI1 enhances erastin-induced ferroptosis. Furthermore, combining EZH2 inhibitors with erastin similarly promotes ferroptosis in renal cancer cells. Mechanistically, SPI1 transcriptionally suppresses ACSL4 expression through the EZH2/H3K27me3 pathway, leading to inhibition of intracellular lipid peroxidation. Thus, SPI1 knockdown synergizes with erastin to promote lipid peroxidation and ferroptosis, suggesting that targeting SPI1 may represent a promising therapeutic strategy for renal cell carcinoma.


  • Exploring promising biomarkers based on pathogenic mechanisms in interstitial cystitis/bladder pain syndrome

    by Kerong Xin, Siyu Wu, Rong Li, Chiyu Tan, Yuanhong Jiang, Jiazheng Yu, Xu Liu, Shijie Li, Zhenhua Li, Xiaonan Chen

    Interstitial cystitis/bladder pain syndrome (IC/BPS), characterized by bladder discomfort and lower urinary tract symptoms, is often either overtreated or undertreated owing to the complexity and variability of symptoms and the lack of reliable diagnostic tools, leading to reduced quality of life and prolonged illness. The pathophysiology of IC/BPS remains unclear, with multiple hypotheses — such as autoimmune inflammation, oxidative stress and urothelial dysfunction — offering potential explanations. Consequently, a diverse range of urinary biomarkers has emerged, although their diagnostic reliability remains inconsistent. As technology advances, biomarkers are increasingly shifting towards multiplex assays, encompassing genomics, transcriptomics, proteomics and cell-based methods; however, cutting-edge research and clinical validation are not yet integrated into the limited diagnostic tools available. Clinical phenotypes from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network studies provide multi-level biomarker research — including molecular, imaging and other modalities — to support the diagnosis of IC/BPS. Integrating these observations will advance the development of precision medicine for the diagnosis of IC/BPS, thereby improving management of this complex condition.


  • The Association Between Stone Heterogenicity and the Success of Shock Wave Lithotripsy for High Density Upper Urinary Tract Stones: A Muti-Center Prospective Cohort

    by Hanfeng Xu, Junlong Liu, Zheming Li, Chengshan Ge, Hongqiang Guo, Shiyu Song, Zhenhua Li, Song Bai

  • The association between renal pelvis urine density and the risk of severe infectious complications in patient with symptom-free hydronephrosis after shock wave lithotripsy: a multi-center prospective study

    by Dongmei Liu, Junlong Liu, Zheming Li, Chengshan Ge, Hongqiang Guo, Shiyu Song, Zhenhua Li, Song Bai

    Finding reliable and easy-to-obtain predictors of severe infectious complications after shock wave lithotripsy (SWL) is a major clinical need, particular in symptom-free hydronephrosis. Therefore, we aim to prospectively investigate the predictive value of Hounsfield units (HU) in renal pelvis urine for the risk of severe infectious complications in patients with ureteral stones and symptom-free hydronephrosis after SWL. This multi-center prospective study was conducted from June 2020 to December 2023. The HU of renal pelvis urine was measured by non-enhanced computed tomography. The severe infectious complications included systemic inflammatory response syndrome, sepsis, and septic shock. Binary logistic regression models assessed the odds ratios (ORs) and 95% confidence intervals (CIs). Finally, 1,436 patients with ureteral stones were enrolled in this study. 8.9% (128/1,436) of patients experienced severe infectious complications after SWL treatment. After adjusting confounding variables, compared with the patients in the lowest renal pelvis urine density quartile, the OR (95% CI) for the highest quartile was 32.36 (13.32, 78.60). There was a positive linear association between the HU value of renal pelvis urine and the risk of severe infectious complications after SWL (P for trend < 0.001). Furthermore, this association was also observed stratified by age, gender, BMI, stone size, stone location and hydronephrosis grade (all P for interaction > 0.05). Additionally, the nonlinear association employed by restricted cubic splines is not statistically significant (nonlinear P = 0.256). The AUROC and 95%CI of renal pelvis urine density were 0.895 (0.862 to 0.927, P value < 0.001). The cut-off value was 12.0 HU with 78.59% sensitivity and 85.94% specificity. This multi-center prospective study demonstrated a positive linear association between HU in renal pelvis urine and the risk of severe infectious complications in patients with ureteral stones and symptom-free hydronephrosis after SWL, regardless of age, gender, BMI, stone size, stone location, and hydronephrosis grade. These findings might be helpful in the SWL treatment decision-making process.


  • AUTHOR REPLY

    by Zhiqiang Cao, Zhenhua Li